198 related articles for article (PubMed ID: 26563400)
1. Gleason grading challenges in the diagnosis of prostate adenocarcinoma: experience of a single institution.
Chen SD; Fava JL; Amin A
Virchows Arch; 2016 Feb; 468(2):213-8. PubMed ID: 26563400
[TBL] [Abstract][Full Text] [Related]
2. Gleason score 3 + 4=7 prostate cancer with minimal quantity of gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen.
Huang CC; Kong MX; Zhou M; Rosenkrantz AB; Taneja SS; Melamed J; Deng FM
Am J Surg Pathol; 2014 Aug; 38(8):1096-101. PubMed ID: 24832163
[TBL] [Abstract][Full Text] [Related]
3. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.
Flood TA; Schieda N; Keefe DT; Breau RH; Morash C; Hogan K; Belanger EC; Mai KT; Robertson SJ
Virchows Arch; 2016 Sep; 469(3):313-9. PubMed ID: 27394432
[TBL] [Abstract][Full Text] [Related]
4. Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy.
Faraj SF; Bezerra SM; Yousefi K; Fedor H; Glavaris S; Han M; Partin AW; Humphreys E; Tosoian J; Johnson MH; Davicioni E; Trock BJ; Schaeffer EM; Ross AE; Netto GJ
PLoS One; 2016; 11(1):e0146189. PubMed ID: 26731672
[TBL] [Abstract][Full Text] [Related]
5. The value of second-opinion pathology diagnoses on prostate biopsies from patients referred for management of prostate cancer.
Barqawi AB; Turcanu R; Gamito EJ; Lucia SM; O'Donnell CI; Crawford ED; La Rosa DD; La Rosa FG
Int J Clin Exp Pathol; 2011 Jun; 4(5):468-75. PubMed ID: 21738818
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Preoperative and Radical Prostatectomy Gleason Score: Examining the Predictors of Upgrade and Downgrade Results.
Pourmand G; Gooran S; Hossieni SR; Guitynavard F; Safavi M; Sharifi A; Mokhtari E
Acta Med Iran; 2017 Apr; 55(4):249-253. PubMed ID: 28532136
[TBL] [Abstract][Full Text] [Related]
7. Downgrading of biopsy based Gleason score in prostatectomy specimens.
Treurniet KM; Trudel D; Sykes J; Evans AJ; Finelli A; Van der Kwast TH
J Clin Pathol; 2014 Apr; 67(4):313-8. PubMed ID: 24403214
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of prostate biopsy undergrading in an academic and community setting.
Mortezavi A; Keller EX; Poyet C; Hermanns T; Saba K; Randazzo M; Fankhauser CD; Wild PJ; Moch H; Sulser T; Eberli D
World J Urol; 2016 Oct; 34(10):1481-90. PubMed ID: 26931560
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.
Ellis CL; Partin AW; Han M; Epstein JI
J Urol; 2013 Dec; 190(6):2068-73. PubMed ID: 23727307
[TBL] [Abstract][Full Text] [Related]
10. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
11. The association of the cribriform pattern with outcome for prostatic adenocarcinomas.
Kir G; Sarbay BC; Gümüş E; Topal CS
Pathol Res Pract; 2014 Oct; 210(10):640-4. PubMed ID: 25042388
[TBL] [Abstract][Full Text] [Related]
12. Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years.
Rajinikanth A; Manoharan M; Soloway CT; Civantos FJ; Soloway MS
Urology; 2008 Jul; 72(1):177-82. PubMed ID: 18279938
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Gleason score 3 + 4 = 7 prostate cancer with minimal amounts (<6%) vs ≥6% of Gleason pattern 4 tissue in needle biopsy specimens.
Kır G; Seneldir H; Gumus E
Ann Diagn Pathol; 2016 Feb; 20():48-51. PubMed ID: 26750655
[TBL] [Abstract][Full Text] [Related]
14. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.
Moussa AS; Li J; Soriano M; Klein EA; Dong F; Jones JS
BJU Int; 2009 Jan; 103(1):43-8. PubMed ID: 18782303
[TBL] [Abstract][Full Text] [Related]
15. Patient risk stratification using Gleason score concordance and upgrading among men with prostate biopsy Gleason score 6 or 7.
Serkin FB; Soderdahl DW; Cullen J; Chen Y; Hernandez J
Urol Oncol; 2010; 28(3):302-7. PubMed ID: 19117774
[TBL] [Abstract][Full Text] [Related]
16. Primary Gleason pattern in biopsy Gleason score 7 is predictive of adverse histopathological features and biochemical failure following radical prostatectomy.
Berg KD; Røder MA; Brasso K; Vainer B; Iversen P
Scand J Urol; 2014 Apr; 48(2):168-76. PubMed ID: 23889119
[TBL] [Abstract][Full Text] [Related]
17. Extraprostatic Extension Is Extremely Rare for Contemporary Gleason Score 6 Prostate Cancer.
Anderson BB; Oberlin DT; Razmaria AA; Choy B; Zagaja GP; Shalhav AL; Meeks JJ; Yang XJ; Paner GP; Eggener SE
Eur Urol; 2017 Sep; 72(3):455-460. PubMed ID: 27986368
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of the 2005 International Society of Urologic Pathology Gleason grading system in prostate biopsy and radical prostatectomy specimens.
Uemura H; Hoshino K; Sasaki T; Miyoshi Y; Ishiguro H; Inayama Y; Kubota Y
BJU Int; 2009 May; 103(9):1190-4. PubMed ID: 19076142
[TBL] [Abstract][Full Text] [Related]
20. Revised Gleason grading system is a better predictor of indolent prostate cancer at the time of diagnosis: retrospective clinical-pathological study on matched biopsy and radical prostatectomy specimens.
Giunchi F; Brunocilla E; Borghesi M; Rizzi S; Ricci MS; Romagnoli D; Martorana G; Schiavina R; Fiorentino M
Clin Genitourin Cancer; 2014 Oct; 12(5):325-9. PubMed ID: 24583160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
